SV2010003730A - QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTS - Google Patents
QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTSInfo
- Publication number
- SV2010003730A SV2010003730A SV2010003730A SV2010003730A SV2010003730A SV 2010003730 A SV2010003730 A SV 2010003730A SV 2010003730 A SV2010003730 A SV 2010003730A SV 2010003730 A SV2010003730 A SV 2010003730A SV 2010003730 A SV2010003730 A SV 2010003730A
- Authority
- SV
- El Salvador
- Prior art keywords
- muscarinic receptors
- quinuclidine derivatives
- receptors antagonists
- quinuclidine
- pharmaceutical compositions
- Prior art date
Links
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title abstract 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title abstract 2
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical class C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LOS COMPUESTOS NOMBRADOS DE FORMULA (I): (VER FORMULA); EN LA QUE R4 ES UNA QUINUCLIDINA N-SUSTITUIDA (I), COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y UN PROCESO PARA PREPARAR LAS COMPOSICIONES FARMACÉUTICAS. TAMBIÉN SE DIVULGA SU USO EN TERAPIA PARA EL TRATAMIENTO DE AFECCIONES MEDIADAS POR RECEPTORES MUSCARINICOS M3, TALES COMO LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICATHE APPOINTMENT COMPOUNDS OF FORMULA (I): (SEE FORMULA); IN WHICH R4 IS AN N-REPLACED QUINUCLIDINE (I), PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND A PROCESS TO PREPARE PHARMACEUTICAL COMPOSITIONS. IT IS ALSO DISCLOSED ITS USE IN THERAPY FOR THE TREATMENT OF AFFECTIONS MEDIATED BY M3 MUSCARINIC RECEPTORS, SUCH AS THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SV2010003730A SV2010003730A (en) | 2010-11-12 | 2010-11-12 | QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SV2010003730A SV2010003730A (en) | 2010-11-12 | 2010-11-12 | QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2010003730A true SV2010003730A (en) | 2011-03-15 |
Family
ID=44246106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2010003730A SV2010003730A (en) | 2010-11-12 | 2010-11-12 | QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTS |
Country Status (1)
| Country | Link |
|---|---|
| SV (1) | SV2010003730A (en) |
-
2010
- 2010-11-12 SV SV2010003730A patent/SV2010003730A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6321265A2 (en) | COMPOUNDS OF 2-AMIDO-3-METHYL PIRROID PYRIMIDINONE PHENYL-REPLACED AS BACE-1 INHIBITORS COMPOSITIONS AND ITS USE | |
| ECSP14013217A (en) | 4-IMIDAZOPIRIDAZIN-1-IL-BENZAMIDAS AND 4-IMIDAZOTRIAZIN-1-IL-BENZAMIDAS AS BTK INHIBITORS. | |
| EA201490320A1 (en) | TETRAHYDROPYRIDOPYRIDINE AND TETRAHYDROPYRIDOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION AS MODEL C5A RECEPTOR MODULATORS | |
| HN2010002403A (en) | QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECEPTORS ANTAGONISTS | |
| EA201491060A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| EA201492023A1 (en) | REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION | |
| CO6480918A2 (en) | POLYCHYCLIC ANTAGONISTS OF LISOPHOSPHATIDIC ACID RECEPTORS. | |
| EA201490228A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| EA201690247A1 (en) | AMINOMETHYBYRIL DERIVATIVES-INHIBITORS OF COMPLEX D FACTOR AND USE | |
| CO6771417A2 (en) | Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis | |
| CR20140037A (en) | TRPM8 ANTAGONISTS AND ITS USE IN TREATMENTS | |
| GT201400016A (en) | INDAZOLES | |
| BR112015012555A2 (en) | benzimidazole derivatives as ep4 antagonists | |
| CU20130036A7 (en) | TRIAZINA-OXIDAZOLES | |
| BR112016000909A8 (en) | indole piperidinyl derivatives, their uses, and pharmaceutical combination and composition | |
| CO6640327A2 (en) | Pyrazole compounds as sigma receptor inhibitors | |
| EA201591195A1 (en) | NEW QUINOLON DERIVATIVES | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| CL2016000187A1 (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2 (1h) -one derivatives that have muscarinic receptor antagonist activity as well as b2 adrenergic receptor agonist activity. | |
| BR112013004662B8 (en) | Compound, pharmaceutical composition, uses of a compound, and method of preparing a pharmaceutical composition | |
| SMT201200017B (en) | New P2X7R antagonists and their use. | |
| BR112013000059A2 (en) | Piperidine derivatives and their uses for the treatment of metabolic disorders | |
| EA201391797A1 (en) | 3-SPIROCYCLIC PIPERIDINE DERIVATIVES AS AGONISTS OF GREELINE RECEPTORS | |
| WO2012040636A3 (en) | Compounds and methods for treating diseases mediated by protease activated receptors | |
| CL2013002861A1 (en) | Analog compounds of epoxyeicosatrienoic acid, ethers agonists; pharmaceutical composition; and use of the compounds to prepare useful medications to treat hypertension and induced nephrotoxicity medications, such as cisplatin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |